Patents by Inventor Kenneth W. Adams

Kenneth W. Adams has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190274992
    Abstract: In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier; and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
    Type: Application
    Filed: May 28, 2019
    Publication date: September 12, 2019
    Inventor: Kenneth W. Adams
  • Patent number: 10403252
    Abstract: A communication system provides connection, configuration, and control of a musical instrument. A musical instrument includes a first communication link disposed on the musical instrument. Various music related accessories, such as a speaker, effects pedal, computer, mobile communication device, and synthesizer, includes a second communication link. A communication link transmits and receives the audio signal and control data between the musical instrument and accessories through the first and second communication links. A controller receives the audio signal and control data for configuring and controlling the device. The communication link is further connected to a computer, mobile communication device, and server through a communication network. A web server interface is coupled to the communication link for user selection and viewing of the control data in human perceive form.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: September 3, 2019
    Assignee: Fender Musical Instruments Corporation
    Inventors: Keith L. Chapman, Charles C. Adams, Stanley J. Cotey, Kenneth W. Porter
  • Patent number: 10363065
    Abstract: A medical device includes an elongate member. The elongate member has a first end portion and a second end portion. The second end portion of the elongate member has an upper surface and a lower surface disposed opposite the upper surface. The lower surface has a planar portion. The upper surface has a planar portion and a concave portion.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: July 30, 2019
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Kenneth W. Adams, Kenneth M. Flynn, Peter S. Finamore, Andrew Dolan
  • Patent number: 10350190
    Abstract: In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier; and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
    Type: Grant
    Filed: December 3, 2010
    Date of Patent: July 16, 2019
    Assignee: DR. KENNETH ADAMS MEDICINE PROFESSIONAL CORPORATION
    Inventor: Kenneth W. Adams
  • Patent number: 10219829
    Abstract: According to an aspect, a medical device includes a needle member having a curved portion, a handle coupled to the needle member, and a pusher member including a sheath and an extension member. The sheath may be bendable. The extension member is configured to be slidably coupled to a track of the handle such that extension member slides within the track during a medical procedure. The sheath defines a lumen configured to receive a portion of the needle member. The extension member is configured to be de-coupled from the track of the handle after the medical procedure. The sheath is configured to be de-coupled from the needle member after the medical procedure. In some examples, the sheath of the pusher member is configured to bend to conform to the curved portion when the sheath of the pusher member is moved over the curved portion of the needle member.
    Type: Grant
    Filed: September 10, 2015
    Date of Patent: March 5, 2019
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Peter J. Pereira, Kenneth W. Adams, Michael S. H. Chu, John Goncalves, Sharmad S. Joshi
  • Patent number: 9713518
    Abstract: Some embodiments are directed to implants and methods for making and using the implants. An exemplary implant includes a first elongate member and a second elongate member each having a first end portion and a second end portion. The first and second end portions of the first elongate member may be configured to be coupled to tissue of a patient proximate the vagina and sacrum, respectively. The first elongate member may define a first opening and a second opening, where the second elongate member may be configured to extend through the first opening and the second opening. The first end portion of the second elongate member may be coupled to tissue proximate the vagina of the patient.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: July 25, 2017
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Kenneth W. Adams, David L. Mason, James M. Goddard
  • Publication number: 20170087164
    Abstract: A pharmaceutical composition for enhancing male erectile function comprising an erectile function-enhancing amount of an insulin-like growth factor selected from the group consisting of IGF-1 (Somatmedin-C) and analogue LR3 IGF1 in admixture with a pharmaceutically-acceptable diluents or carrier. Such compositions optionally further comprise compounds selected from an androgen, particularly, testosterone and dihydrotestosterone, a vasodilator, PDE5 inhibitor and prostaglandin E1.
    Type: Application
    Filed: December 12, 2016
    Publication date: March 30, 2017
    Inventor: Kenneth W. Adams
  • Publication number: 20170027659
    Abstract: According to an aspect, a medical device includes a needle member and a handle member. The handle member is coupled to the needle member. The handle member has a substantially flat portion. The handle member defines a groove. The groove is disposed on the substantially flat portion of the handle member.
    Type: Application
    Filed: July 26, 2016
    Publication date: February 2, 2017
    Inventors: James M. Goddard, Kenneth W. Adams, Doreen Rao
  • Patent number: 9545395
    Abstract: A pharmaceutical composition for enhancing male erectile function comprising an erectile function-enhancing amount of an insulin-like growth factor selected from the group consisting of IGF-1 (Somatmedin-C) and analog LR3 IGF1 in admixture with a pharmaceutically-acceptable diluents or carrier. Such compositions optionally further comprise compounds selected from an androgen, particularly, testosterone and dihydrotestosterone, a vasodilator, PDE5 inhibitor and prostaglandin E1.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: January 17, 2017
    Inventor: Kenneth W. Adams
  • Publication number: 20160074147
    Abstract: According to an aspect, a medical device includes a needle member having a curved portion, a handle coupled to the needle member, and a pusher member including a sheath and an extension member. The sheath may be bendable. The extension member is configured to be slidably coupled to a track of the handle such that extension member slides within the track during a medical procedure. The sheath defines a lumen configured to receive a portion of the needle member. The extension member is configured to be de-coupled from the track of the handle after the medical procedure. The sheath is configured to be de-coupled from the needle member after the medical procedure. In some examples, the sheath of the pusher member is configured to bend to conform to the curved portion when the sheath of the pusher member is moved over the curved portion of the needle member.
    Type: Application
    Filed: September 10, 2015
    Publication date: March 17, 2016
    Inventors: Peter J. Pereira, Kenneth W. Adams, Michael S.H. Chu, John Goncalves, Sharmad S. Joshi
  • Publication number: 20160038179
    Abstract: According to an aspect, a medical device may include a needle member, and a handle coupled to the needle member. The handle may define a track portion. The medical device may also include a pusher member having a sheath disposed around a portion of the needle member, and an extension member being movably coupled to the track portion of the handle such that the pusher member is configured to move from a first position to a second position during a surgical procedure. The pusher member may be removable from the handle. The sheath may define a slot, and the pusher member may be removable from the needle member through the slot.
    Type: Application
    Filed: August 4, 2015
    Publication date: February 11, 2016
    Inventors: Doreen S. Rao, James M. Goddard, Joshin Sahadevan, Gururaju Chikkaraju, Michael S.H. Chu, Kenneth W. Adams
  • Publication number: 20150157438
    Abstract: Some embodiments are directed to implants and methods for making and using the implants. An exemplary implant includes a first elongate member and a second elongate member each having a first end portion and a second end portion. The first and second end portions of the first elongate member may be configured to be coupled to tissue of a patient proximate the vagina and sacrum, respectively. The first elongate member may define a first opening and a second opening, where the second elongate member may be configured to extend through the first opening and the second opening. The first end portion of the second elongate member may be coupled to tissue proximate the vagina of the patient.
    Type: Application
    Filed: December 8, 2014
    Publication date: June 11, 2015
    Inventors: Kenneth W. Adams, David L. Mason, James M. Goddard
  • Publication number: 20150105792
    Abstract: A medical device includes an elongate member. The elongate member has a first end portion and a second end portion. The second end portion of the elongate member has an upper surface and a lower surface disposed opposite the upper surface. The lower surface has a planar portion. The upper surface has a planar portion and a concave portion.
    Type: Application
    Filed: October 14, 2014
    Publication date: April 16, 2015
    Inventors: Kenneth W. Adams, Kenneth M. Flynn, Peter S. Finamore, Andrew Dolan
  • Patent number: 8993558
    Abstract: A composition, use of and a method of removing a hyperplastic skin lesion on a mammal comprising administering to the lesion or locus thereof a therapeutically effective amount of a composition comprising a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof and a pharmaceutically acceptable diluent or carrier.
    Type: Grant
    Filed: October 29, 2009
    Date of Patent: March 31, 2015
    Inventor: Kenneth W. Adams
  • Publication number: 20140235601
    Abstract: The use of an aromatase blocker or an estrogen blocker is described in a method for increasing spermatogenesis and Seritolli cell function, and/or improving Leydig cell function, in order to to increase endogenous testosterone levels in a male mammal. The levels of active materials used are significantly lower than the levels of these materials used to treat female estrogen sensitive tumors.
    Type: Application
    Filed: August 9, 2012
    Publication date: August 21, 2014
    Inventor: Kenneth W. Adams
  • Publication number: 20120283186
    Abstract: A method and device to deliver medication in a liquid, gel or suspension formulation to a plurality of adjacent tissue sites of a mammal, the device comprising a plurality of tissue-engaging members for receiving the medication and operably engageable with the plurality of tissue sites; means for supplying the tissue-engaging members with the formulation, and to temporarily sustain and control the rate of therapeutic agent/unit of time and preferably to sustain these controlled delivery rates over extended periods of time to enhance the local therapeutic effect of these therapeutic agents and to reduce the systemic toxicity and reduce unwanted side effects.
    Type: Application
    Filed: December 3, 2010
    Publication date: November 8, 2012
    Applicant: ADAMS PATENT CORPORATION
    Inventor: Kenneth W. Adams
  • Publication number: 20120245145
    Abstract: In the broadest aspect, the invention provides a composition for and a method of prophylactic and/or therapeutic treatment of a animal/mammal for any viral disease, mixed bacterial and viral infections, bacterial infections, bacterial endotoxins, bacterial exotoxins, autoimmune diseases, and cellular or humoral mediated allergic conditions that is caused by any virus that relies on the maintenance of specific calcium ion concentrations for the post ribosomal RNA synthesis processing of viral protein translation, transportation and processing of viral structural components by utilizing a therapeutic amount of a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof, and a pharmaceutical acceptable diluent or carrier; and/or is caused by damage to the animal/mammal by a pathological immune response to antigens.
    Type: Application
    Filed: December 3, 2010
    Publication date: September 27, 2012
    Inventor: Kenneth W. Adams
  • Publication number: 20120245088
    Abstract: Pharmaceutical compositions and methods for improving functional capacity of tissues and organs in both healthy and pathologic disease states for: reducing unwanted cosmetic effects of aging on the skin to reduce wrinkles, to increase collagen and water content, thicken and increase skin volume and to maintain a youthful appearance to age and sun damaged skin, to treat diseases of skin and tissues caused by ischemia of venous congestion and arterial insufficiency, to accelerate healing of tendons, ligaments, joints, cartilage, nerves, bones or neuromuscular injuries or diseases, to improve and restore the functional capacity of specific tissues and organs of the body, and to treat hair loss comprising an effective amount of an insulin-like growth factor selected from the group consisting of IGF-1 (Somatmedin-C) and analogue LR3 IGF1 in admixture with a pharmaceutically-acceptable diluent or carrier.
    Type: Application
    Filed: December 3, 2010
    Publication date: September 27, 2012
    Inventor: Kenneth W. Adams
  • Patent number: 8162819
    Abstract: A penis tensioning device effecting penis tissue modeling and penis enlargement, the device comprising an elongate tensioning, biasing member having a first portion (14) and a second portion; first retaining means connected to the first portion (14) and Cooperable in tight-fitting engagement with a portion of the penis adjacent the head; second retaining means connected to the second portion and cooperable with a distal member selected from the group consisting of an article of clothing, a body part and an inanimate object.
    Type: Grant
    Filed: August 11, 2006
    Date of Patent: April 24, 2012
    Inventor: Kenneth W. Adams
  • Publication number: 20110319382
    Abstract: A composition, use of and a method of removing a hyperplastic skin lesion on a mammal comprising administering to the lesion or locus thereof a therapeutically effective amount of a composition comprising a blocker selected from the group consisting of a calcium channel blocker, a metabolite thereof, a calmodulin blocker and a metabolite thereof and a pharmaceutically acceptable diluent or carrier.
    Type: Application
    Filed: October 29, 2009
    Publication date: December 29, 2011
    Inventor: Kenneth W. Adams